Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.

Abstract

The acute myeloid leukaemia (AML) 99 trial conducted previously in Japan for the treatment of de novo paediatric AML showed excellent results, with a 5-year overall survival (OS) and event-free survival (EFS) of 75·6% and 61·6%, respectively. To examine reproducibility of these results in another cohort, the outcome of 146 newly diagnosed AML paediatric… (More)
DOI: 10.1111/bjh.12030

Topics

Cite this paper

@article{Imamura2012OutcomeI1, title={Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study.}, author={Toshihiko Imamura and Shotaro Iwamoto and Rie Kanai and Akira Shimada and Kiminori Terui and Yuko Osugi and Ryoji Kobayashi and Akio Tawa and Yoshiyuki Kosaka and Koji Kato and Hiroki Hori and Keizo Horibe and M. Oda and S. Adachi}, journal={British journal of haematology}, year={2012}, volume={159 2}, pages={204-10} }